🔎 Trials Near Me

首页 › 非小细胞肺癌 › 北达科他州

北达科他州 的 非小细胞肺癌 临床试验

北达科他州 有 15 项针对 非小细胞肺癌 的研究正在招募参与者。

北达科他州 的城市

官方研究文本（英文）

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Sanford Bismarck Medical Center, Bismarck
  • Sanford Broadway Medical Center, Fargo
  • Sanford Roger Maris Cancer Center, Fargo
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

  • Sanford Bismarck Medical Center, Bismarck
  • Sanford Broadway Medical Center, Fargo
  • Sanford Roger Maris Cancer Center, Fargo
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT07293247

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

  • Sanford Fargo Medical Center ( Site 3236), Fargo
  • Altru Health System ( Site 3254), Grand Forks
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT07513376

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Sanford Bismarck Medical Center, Bismarck
  • Essentia Health Cancer Center-South University Clinic, Fargo
  • Sanford Broadway Medical Center, Fargo
  • 以及另外 1 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06498635

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0057), Fargo
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06312137

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

  • Research Site, Grand Forks
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月18日 · NCT06692738

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

  • Sanford Fargo Medical Center ( Site 0039), Fargo
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年8月25日 · NCT04165070

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

  • Sanford Fargo Medical Center ( Site 0039), Fargo
招募中观察性研究
18 岁及以上 · 所有性别 · 更新于 2026年8月25日 · NCT04165798

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

  • Sanford Fargo Medical Center ( Site 0039), Fargo
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年8月18日 · NCT06731907

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • Sanford Roger Maris Cancer Center, Fargo
招募中2 期
18 至 70 岁 · 所有性别 · 更新于 2026年6月26日 · NCT04614103

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Sanford Bismarck Medical Center, Bismarck
  • Sanford Broadway Medical Center, Fargo
  • Sanford Roger Maris Cancer Center, Fargo
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年6月3日 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Sanford Bismarck Medical Center, Bismarck
  • Sanford Broadway Medical Center, Fargo
  • Sanford Roger Maris Cancer Center, Fargo
招募中2 期
18 Minutes · 所有性别 · 更新于 2026年5月5日 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Sanford Bismarck Medical Center, Bismarck
  • Essentia Health Cancer Center-South University Clinic, Fargo
  • Sanford Broadway Medical Center, Fargo
  • 以及另外 1 项
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年5月5日 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Essentia Health Cancer Center-South University Clinic, Fargo
招募中观察性研究
18 岁及以上 · 所有性别 · 更新于 2026年3月17日 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Fargo
招募中观察性研究
所有年龄段 · 所有性别 · 更新于 2025年10月28日 · NCT03452774

数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。